Targeting type 2 inflammation in bullous pemphigoid: dupilumab as a game changer opens new avenues

被引：0
|
作者：
Borradori, Luca [1 ]
Hertl, Michael [2 ]
机构：
[1] Univ Bern, Univ Hosp Bern, Dept Dermatol, Bern, Switzerland
[2] Philipps Univ, Dept Dermatol & Allergol, Marburg, Germany
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2025年 / 192卷 / 03期
关键词：
D O I：
10.1093/bjd/ljae465
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：377 / 378
页数：2
相关论文
共 50 条
  • [41] Human bullous pemphigoid antigen 2 transgenic skin elicits specific IgG in wild type mice
    Olasz, Edit
    Roh, Jooyoung
    Yee, Carole
    Arita, Ken
    Akiyama, Masashi
    Shimizu, Hiroshi
    Vogel, Jonathan
    Yancey, Kim B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (10) : 2351 - 2351
  • [42] Targeting inflammation to reduce ASCVD in type 2 diabetes
    Jialal, Ishwarlal
    Chaudhuri, Ajay
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2019, 33 (01) : 1 - 3
  • [43] Dupilumab efficacy in patients with COPD and type 2 inflammation irrespective of mortality risk score
    Vogelmeier, Claus
    Rabe, Klaus F.
    Bhatt, Surya P.
    Hanania, Nicola A.
    Bafadhel, Mona
    Christenson, Stephanie A.
    Papi, Alberto
    Singh, Dave
    Laws, Elizabeth
    Maloney, Jennifer
    Lu, Xin
    Bauer, Deborah
    Bansal, Ashish
    Robinson, Lacey B.
    Abdulai, Raolat M.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [44] Elevated Eosinophil Count Associated with Dupilumab Therapy in Patients with Type-2 Inflammation
    Klimek, Ludger
    Spielhaupter, Magdalena
    Alali, Ali
    Cichy, Marc
    Huppertz, Tilman
    Hagemann, Jan
    LARYNGO-RHINO-OTOLOGIE, 2020, 99 (11) : 811 - 812
  • [45] Efficacy of dupilumab in Asian patients with chronic obstructive pulmonary disease with type 2 inflammation
    Bhatt, Surya P.
    Rabe, Klaus F.
    Hanania, Nicola A.
    Vogelmeier, Claus
    Cole, Jeremy
    Bafadhel, Mona
    Christenson, Stephanie A.
    Papi, Alberto
    Singh, Dave
    Laws, Elizabeth
    Wen, Fuqiang
    Mortensen, Eric R.
    Maloney, Jennifer
    Lu, Xin
    Bauer, Deborah
    Bansal, Ashish
    Robinson, Lacey B.
    Abdulai, Raolat M.
    RESPIROLOGY, 2023, 28 : 296 - 297
  • [46] Dupilumab in type 2 airway inflammation-a step forward in targeted therapy for COPD
    Tan, Ronnie Voon Shiong
    Aung, Hnin Wint Wint
    Flynn, Cara
    Greening, Neil J.
    Brightling, Christopher E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : 404 - 406
  • [47] New avenues for the prevention of colorectal cancer: targeting cyclo-oxygenase-2 activity
    Gupta, RA
    DuBois, RN
    Wallace, MC
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2002, 16 (06) : 945 - 956
  • [48] Human bullous pemphigoid antigen 2 transgenic skin elicits specific IgG in wild-type mice
    Olasz, Edit B.
    Roh, Jooyoung
    Yee, Carole L.
    Arita, Ken
    Akiyama, Masashi
    Shimizu, Hiroshi
    Vogel, Jonathan C.
    Yancey, Kim B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (12) : 2807 - 2817
  • [49] Blister Fluid Induces MMP-9-Associated M2-Type Macrophages in Bullous Pemphigoid
    Riani, Meriem
    Muller, Celine
    Bour, Camille
    Bernard, Philippe
    Antonicelli, Frank
    Le Jan, Sebastien
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [50] Bullous Pemphigoid Associated with Dipeptidyl Peptidase 4 Inhibitors for the Treatment of Type 2 Diabetes: A Multicenter Study in Istanbul
    Ugurer, Ece
    Ozkur, Ezgi
    Altunay, Ilknur Kivanc
    Sen, Esra Cil
    Aksu, Ayse Esra Koku
    Ozcan, Ilknur
    Altuntas, Yuksel
    Gurel, Mehmet Salih
    MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2022, 56 (03): : 375 - 380
12345